An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 174 participants.
Also called NCT03187522
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT03187522
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT03187522. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-22 (actual); primary completion 2020-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft
- Condition
- Aortic Aneurysm, Abdominal
- Intervention (Device)
- TREO Stent-Graft System
- Lead sponsor
- Bolton Medical
- Collaborator
- Bolton Medical Espana SLU
Record details
- Record id
cardio:ct-nct03187522- Content hash
5ba26636f17138c9fd4472700a65435bf08ef3645fb5c7ff0933425c0f49b4d0